Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −156,214−100.0% | Sold out | Holders |
| Q3 2023 | 156,214 | $1.20M | <0.1% | +14,818+10.5% | Added | Holders |
| Q2 2023 | 141,396 | $1.06M | <0.1% | +15,385+12.2% | Added | Holders |
| Q1 2023 | 126,011 | $840.5K | <0.1% | +2,846+2.3% | Added | Holders |
| Q4 2022 | 123,165 | $949.6K | <0.1% | +32,977+36.6% | Added | Holders |
| Q3 2022 | 90,188 | $960.0K | <0.1% | −12,102−11.8% | Reduced | Holders |
| Q2 2022 | 102,290 | $833.0K | <0.1% | −71,388−41.1% | Reduced | Holders |
| Q1 2022 | 173,678 | $1.24M | <0.1% | −10,936−5.9% | Reduced | Holders |
| Q4 2021 | 184,614 | $3.16M | <0.1% | +184,614 | New | Holders |